Format

Send to

Choose Destination
PLoS Med. 2011 Jul;8(7):e1001063. doi: 10.1371/journal.pmed.1001063. Epub 2011 Jul 26.

Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis.

Author information

1
Department of Medicine, University of California, San Francisco, California, United States of America. ddowdy@jhsph.edu

Abstract

David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.

PMID:
21814496
PMCID:
PMC3144197
DOI:
10.1371/journal.pmed.1001063
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center